PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia

被引:24
作者
Goyal, Amrita [1 ]
Moore, Johanna B. [1 ]
Gimbel, Devon [1 ]
Carter, Joi B. [1 ]
Kroshinsky, Daniela [1 ]
Ferry, Judith A. [1 ]
Harris, Nancy L. [1 ]
Duncan, Lyn M. [1 ]
机构
[1] Massachusetts Gen Hosp, Dermatopathol Unit, Boston, MA 02114 USA
关键词
CD1a; lymphoid hyperplasia; MALT lymphoma; PD-1; pseudolymphomatous folliculitis; PROGRAMMED DEATH-1; ENTITIES; TISSUE; SKIN;
D O I
10.1111/cup.12440
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundPseudolymphomatous folliculitis is a lymphoid proliferation that clinically and histopathologically mimics primary cutaneous extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In this study, we assessed the diagnostic value of three immunohistochemical markers, programmed death-1 (PD-1), CD1a and S100. MethodsWe evaluated 25 cases of cutaneous lymphoid proliferations with established diagnoses, including 9 patients with pseudolymphomatous folliculitis, 11 with MALT lymphoma, and 5 with cutaneous lymphoid hyperplasia (CLH). The clinical, histopathologic and immunohistochemical characteristics were reviewed and three major characteristics assessed: (a) proportion of T cells expressing PD-1, (b) pattern of expression of CD1a by dendritic cells and (c) pattern of expression of S100 by dendritic cells. ResultsWe found pseudolymphomatous folliculitis to have a significant increase in PD-1+ T cells compared with MALT lymphoma (p < 0.0001). The pattern of CD1a staining is also informative: MALT lymphoma is significantly more likely to demonstrate a peripheral concentration of CD1a+ dendritic cells around lymphoid nodules than pseudolymphomatous folliculitis (p < 0.0003) or CLH (p < 0.05). Pseudolymphomatous folliculitis demonstrates an interstitial distribution of CD1a+ cells more often than MALT lymphoma (p < 0.04). S100 staining was not a helpful discriminator. ConclusionsHistopathologic factors including PD-1 and CD1a staining patterns may allow for more certainty in distinguishing lymphoid hyperplasia, including pseudolymphomatous folliculitis, from MALT lymphoma.
引用
收藏
页码:6 / 15
页数:10
相关论文
共 14 条
  • [1] Distribution of CD1a-positive cells is not different between pseudolymphomatous folliculitis and primary cutaneous marginal zone lymphoma
    Shojiguchi, Naoko
    Arai, Eiichi
    Anan, Takashi
    Ansai, Shin-ichi
    Tsuchida, Tetsuya
    Yasuda, Masanori
    JOURNAL OF DERMATOLOGY, 2021, 48 (04) : 464 - 469
  • [2] Primary cutaneous marginal zone B-Cell lymphoma of MALT type in a child
    Dargent, Jean-Louis
    Devalck, Christine
    de Mey, Albert
    Vandeweyer, Eric
    Lespagnard, Laurence
    Heimann, Pierre
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2006, 9 (06) : 468 - 473
  • [3] Primary cutaneous marginal zone B-cell lymphoma
    Tsuji, K
    Suzuki, D
    Naito, Y
    Sato, Y
    Yoshino, T
    Iwatsuki, K
    EUROPEAN JOURNAL OF DERMATOLOGY, 2005, 15 (06) : 480 - 483
  • [4] Primary cutaneous CD5+marginal zone B-cell lymphoma resembling the plasma cell variant of Castleman's disease
    Tsukamoto, Norifumi
    Kojima, Masaru
    Uchiyama, Toshimasa
    Takeuchi, Tokio
    Karasawa, Masamitsu
    Murakami, Hirokazu
    Sato, Sadao
    APMIS, 2007, 115 (12) : 1426 - 1431
  • [5] CD123-positive Plasmacytoid Dendritic Cells in Primary Cutaneous Marginal Zone B-cell Lymphoma Diagnostic and Pathogenetic Implications
    Kutzner, Heinz
    Kerl, Helmut
    Pfaltz, Monique C.
    Kempf, Werner
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (09) : 1307 - 1313
  • [6] Large Cells With CD30 Expression and Hodgkin-like Features in Primary Cutaneous Marginal Zone B-Cell Lymphoma A Study of 13 Cases
    Prieto-Torres, Lucia
    Manso, Rebeca
    Elisabeth Cieza-Diaz, Deysy
    Jo, Margarita
    Kilany Perez, Linah
    Montenegro-Damaso, Tarsila
    Erana, Itziar
    Lorda, Marta
    Suarez Massa, Dolores
    Machan, Salma
    Cordoba, Raul
    Ara, Mariano
    Requena, Luis
    Rodriguez-Pinilla, Socorro M.
    Piris, Miguel A.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (09) : 1191 - 1202
  • [7] Bi-clonal, multifocal primary cutaneous marginal zone B-cell lymphoma: report of a case and review of the literature
    Nicholson, Kimberly M.
    Patel, Keyur P.
    Duvic, Madeleine
    Prieto, Victor G.
    Tetzlaff, Michael T.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2012, 39 (09) : 866 - 871
  • [8] Nodular localized primary cutaneous amyloidosis and primary marginal zone B-cell lymphoma on the nose: treatment with microscopically controlled surgery
    Kendler, Michael
    Helbig, Doris
    Paasch, Uwe
    Kutzner, Heinz
    Simon, Jan Christoph
    Wetzig, Tino
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2011, 50 (04) : 458 - 461
  • [9] Immunohistochemical expression of cereblon and MUM1 as potential predictive markers of response to lenalidomide in extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)
    Kiesewetter, Barbara
    Simonitsch-Klupp, Ingrid
    Kornauth, Christoph
    Dolak, Werner
    Lukas, Julius
    Mayerhoefer, Marius E.
    Raderer, Markus
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 62 - 67
  • [10] IRTA1 positivity helps identify a MALT-lymphoma-like subset of primary cutaneous marginal zone lymphomas, largely but not exclusively defined by IgM expression
    Carlsen, Eric D.
    Bhavsar, Shweta
    Cook, James R.
    Swerdlow, Steven H.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2022, 49 (01) : 55 - 60